Darzalex® (daratumumab) – Expanded indication
June 27, 2019 - Janssen announced the FDA approval of Darzalex (daratumumab), in combination with Revlimid® (lenalidomide) and dexamethasone, for the treatment of newly diagnosed multiple myeloma patients who are ineligible for autologous stem cell transplant.
Top